perugu_vada Posted September 10, 2020 Report Posted September 10, 2020 Pfizer, the multinational pharmaceutical company, may be the first in the United States to seek regulatory approval for a COVID-19 vaccine, but even if its vaccine is authorized, the company may face additional challenges in distributing it. That's because Pfizer's vaccine can't be stored in the refrigeration systems found at the typical doctor's office. Instead, it requires special ultra-low-temperature freezers that can store medicine at approximately 94 degrees below zero. The delivery system is complex, requiring the use of a custom-built "cool box" that can store 1,000 to 5,000 vaccines for up to 10 days at minus 94 degrees. Quote
RunRaajaRun123 Posted September 10, 2020 Report Posted September 10, 2020 It is also tough to restore it again, once someone gets an appointment they need to get it ready, if the person misses the appointment unless someone is ready in the queue to take it the dosage goes to waste. Quote
soodhilodaaram Posted September 10, 2020 Report Posted September 10, 2020 those aspects are baked into the cost anyway, or this is the way they can rationalize the high prices Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.